高志伟 Email and Phone Number

ADME (DMPK) Services Across Drug Discovery and Development from the Early Stages, During Candidate Selection and in Early and Late Drug Development.In vitro ADME (Caco-2 permeability, PPB, Blood/Plasma ratio, Enzyme/plasma stability, Transporter, Enzyme inhibition and induction, etc);In vivo Animal (mouse, rat, dog & monkey) PK;Metabolite Identification (plasma, micosome, hepatocyte, S9)Metabolism PhenotypeClinical BA and BE BioanalysisRegulated Bioanalysis

Participate in the designing, implementing, interpreting and reporting of ADME-T related INDs, NDAs and ANDAs studies. Includes design and development of protocols, and study reports.Provide pharmacokinetics expertise to clients (pharmaceutical industry) and act as direct intermediary between the client and project team.Proficient in NCA and bioequivalent analysis using WinNonlin.Good knowledge of physiologically based pharmacokinetic (PBPK) modeling and simulation.Experience of application of allometric scaling, In Vitro-In Vivo Extrapolation (IVIVE) and PBPK (Gastroplus) in human PK prediction.Experience in Watson LIMS system manager